TMCnet News
Research and Markets: Global Hemophilia Pipeline Highlights - 2014DUBLIN --(Business Wire)-- Research and Markets (http://www.researchandmarkets.com/research/strjbk/global_hemophilia) has announced the addition of the "Global Hemophilia Pipeline Highlights - 2014" report to their offering. The latest report "Hemophilia Pipeline Highlights - 2014", provides most up-to-date information on key pipeline molecules in the global hemophilia market. It covers emerging therapies for hemophilia in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, dentifying partners, evaluating opportunities, formulating business development strategies, and executing in-licensing and out-licensing deals. Clinical Trial Stages:
Drug Mechanism Classes:
Company:
Short-term Launch Highlights:
SUMMARY:
Key Topics Covered: 1. Hemophilia Pipeline by Stages 2. Hemophilia Pipeline by Drug Class 3. Hemophilia Pipeline by Company 4. Hemophilia Phase 3 Clinical Trial Insights 5. Hemophilia Phase 2 Clinical Trial Insights 6. Hemophilia Phase 1 Clinical Trial Insights 7. Hemophilia Preclinical Research Insights 8. Hemophilia Discovery Stage Insights 9. Appendix 10. Research Methodology For more information visit http://www.researchandmarkets.com/research/strjbk/global_hemophilia
|